Immune profiling revealed significant upregulation of 20 immune cell types in ANCA-GN.<h4>Conclusions</h4>These findings suggest that mitophagy-immune crosstalk drives ANCA-GN progression, with PYCARD and IFI30 as potential diagnostic biomarkers. The gene discussed is PYCARD; the disease is ganglioneuroma.